Functional	O
characterization	O
of	O
the	O
Aspergillus	B:C0004038
nidulans	I:C0004038
glucosylceramide	B:C0017770
pathway	B:C1704259
reveals	O
that	O
LCB	B:C0017770
Δ8	B:C1158365
-	I:C1158365
desaturation	I:C1158365
and	O
C9	B:C0025723
-	I:C0025723
methylation	I:C0025723
are	O
relevant	O
to	O
filamentous	B:C1156246
growth	I:C1156246
,	O
lipid	B:C1660773
raft	I:C1660773
localization	I:C1660773
and	O
Psd1	B:C0915600
defensin	I:C0915600
activity	O
.	O

C8	B:C0017770
-	I:C0017770
desaturated	I:C0017770
and	I:C0017770
C9	I:C0017770
-	I:C0017770
methylated	I:C0017770
glucosylceramide	I:C0017770
(	O
glucosylceramide	B:C0017770
)	O
is	O
a	O
fungal	B:C0016832
-	O
specific	O
sphingolipid	B:C0037900
that	O
plays	O
an	O
important	O
role	O
in	O
the	O
growth	B:C0018270
and	O
virulence	B:C0042765
of	O
many	O
species	B:C1705920
.	O

In	O
this	O
work	O
,	O
we	O
investigated	O
the	O
contribution	O
of	O
Aspergillus	B:C0004038
nidulans	I:C0004038
sphingolipid	B:C1172420
Δ8	I:C1172420
-	I:C1172420
desaturase	I:C1172420
(	O
sphingolipid	B:C1172420
Δ8	I:C1172420
-	I:C1172420
desaturase	I:C1172420
)	O
,	O
sphingolipid	B:C0025831
C9	I:C0025831
-	I:C0025831
methyltransferases	I:C0025831
(	O
SmtA	B:C0025831
/	O
SmtB	B:C0025831
)	O
and	O
glucosylceramide	B:C0163410
synthase	I:C0163410
(	O
glucosylceramide	B:C0163410
synthase	I:C0163410
)	O
to	O
fungal	B:C0016832
phenotypes	O
,	O
sensitivity	O
to	O
Psd1	B:C0915600
defensin	I:C0915600
and	O
Galleria	B:C0998468
mellonella	I:C0998468
virulence	B:C0042765
.	O

We	O
showed	O
that	O
ΔsdeA	B:C0017260
accumulated	O
C8	B:C0017770
-	I:C0017770
saturated	I:C0017770
and	I:C0017770
unmethylated	I:C0017770
GlcCer	I:C0017770
,	O
while	O
gcsA	B:C1421319
deletion	B:C0017260
impaired	O
glucosylceramide	B:C0017770
synthesis	O
.	O

Although	O
increased	O
levels	O
of	O
unmethylated	B:C0017770
GlcCer	I:C0017770
were	O
observed	O
in	O
smtA	B:C0017337
and	O
smtB	B:C0017337
mutants	B:C0596988
,	O
ΔsmtA	B:C0017260
and	O
wild	B:C1883559
-	I:C1883559
type	I:C1883559
cells	B:C0007634
showed	O
a	O
similar	O
9	B:C0017770
,	I:C0017770
Me	I:C0017770
-	I:C0017770
GlcCer	I:C0017770
content	O
,	O
reduced	O
by	O
50	O
%	O
in	O
the	O
smtB	B:C0017337
disruptant	B:C0596988
.	O

The	O
compromised	O
9	B:C0017770
,	I:C0017770
Me-	I:C0017770
GlcCer	I:C0017770
production	O
in	O
the	O
ΔsmtB	B:C0017260
strain	O
was	O
not	O
accompanied	O
by	O
reduced	O
filamentation	B:C0007613
or	O
defects	O
in	O
cell	B:C0085304
polarity	I:C0085304
.	O

When	O
combined	O
with	O
the	O
smtA	B:C0017337
deletion	B:C0017260
,	O
smtB	B:C0017337
repression	O
significantly	O
increased	O
unmethylated	B:C0017770
GlcCer	I:C0017770
levels	O
and	O
compromised	O
filamentous	B:C1156246
growth	I:C1156246
.	O

Furthermore	O
,	O
sdeA	B:C0017337
and	O
gcsA	B:C1421319
mutants	B:C0596988
displayed	O
growth	B:C0018270
defects	O
and	O
raft	B:C1167250
mislocalization	O
,	O
which	O
were	O
accompanied	O
by	O
reduced	B:C0243095
neutral	I:C0243095
lipids	I:C0243095
levels	I:C0243095
and	O
attenuated	O
G.	B:C0998468
mellonella	I:C0998468
virulence	B:C0042765
in	O
the	O
ΔgcsA	B:C0017260
strain	O
.	O

Finally	O
,	O
ΔsdeA	B:C0017260
and	O
ΔgcsA	B:C0017260
showed	O
increased	O
resistance	O
to	O
Psd1	B:C0915600
,	O
suggesting	O
that	O
glucosylceramide	B:C0017770
synthesis	O
and	O
fungal	B:C0016832
sphingoid	B:C0220807
base	I:C0220807
structure	I:C0220807
specificities	O
are	O
relevant	O
not	O
only	O
to	O
differentiation	O
but	O
also	O
to	O
proper	O
recognition	O
by	O
this	O
antifungal	B:C1136254
defensin	B:C0057256
.	O

